(PDF) A CDK9 Inhibitor May Suppress Tumor Growth and

A CDK9 Inhibitor May Suppress Tumor Growth and Enhance Immunotherapy

Cancer Discovery - United States

doi 10.1158/2159-8290.cd-rw2018-191

Full Text

Abstract

Available in full text

Categories

Date

November 2, 2018

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of Host NOX1 Blocks Tumor Growth and Enhances Checkpoint Inhibitor–based Immunotherapy

Life Science Alliance

Molecular Biology

English

Multiple CDK Inhibitor Dinaciclib Suppresses Neuroblastoma Growth via Inhibiting CDK2 and CDK9 Activity

Scientific Reports

Multidisciplinary

English

Metal Ions May Suppress or Enhance Cellular Differentiation in Candida Albicans and Candida Tropicalis Biofilms

Applied and Environmental Microbiology

Applied Microbiology

English

A Tumor-Peptide Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Anti-Tumor Immunotherapy

Molecular Cancer Therapeutics

Cancer Research

English

Endoplasmic Reticulum Stress Regulates Tumor Growth and Anti-Tumor Immunity: A Promising Opportunity for Cancer Immunotherapy

Cancer Immunology, Immunotherapy

Cancer Research

English

Thrombospondin-2: A Potent Endogenous Inhibitor of Tumor Growth and Angiogenesis

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Inhibition of Gastric Tumor Growth by a Novel Hsp90 Inhibitor

Biochemical Pharmacology

English

The Legumain Protease-Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis Without Toxicity

Organic Chemistry

Molecular Medicine

English

Using Caffeoyl Pyrrolidine Derivative LY52, a Potential Inhibitor of Matrix Metalloproteinase-2, to Suppress Tumor Invasion and Metastasis

International Journal of Molecular Medicine

English